Ciprofloxacin Administration to Very Low Birth Weight Babies has no Effect on Linear Growth in Infancy

There is limited information whether the use of ciprofloxacin in the neonatal period affects the linear growth of very low birth weight (VLBW) babies in infancy. This was a retrospective cohort study on VLBW babies followed up until 12 months corrected age (12-mCA). Exclusions were: infants with no length record taken at 12-mCA, who received ciprofloxacin after neonatal period, were neurologically abnormal, growth retarded in utero or …